MicrosoftTeams-image (5).png
Invea Therapeutics Research to be Showcased at the Prestigious 2023 DDW Meeting
April 26, 2023 08:10 ET | Invea Therapeutics
GUILFORD, Conn., April 26, 2023 (GLOBE NEWSWIRE) -- Invea Therapeutics (Invea), a biotechnology company developing an artificial intelligence (AI) and machine learning (ML) powered pipeline of...
Invea Logo.jpg
Invea Therapeutics Appoints Mr. Jason Fenton to Its Board of Directors
December 06, 2022 08:10 ET | Invea Therapeutics
- Mr. Fenton augments board expertise as the Company readies for Phase 1b/2 execution of lead program targeting mast cell biology - Company also primed to advance additional programs, including a...
Invea Logo.jpg
Invea Therapeutics Announces Poster Presentations at Keystone Symposia Gut-Brain Axis and Digestive Disease Week (DDW2022)
March 17, 2022 08:10 ET | Invea Therapeutics
GUILFORD, Conn., March 17, 2022 (GLOBE NEWSWIRE) -- Invea Therapeutics, Inc., a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug discovery and...